{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:09:06Z","timestamp":1792516146943,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["478818\/2012-2"],"award-info":[{"award-number":["478818\/2012-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["478020\/2012"],"award-info":[{"award-number":["478020\/2012"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","award":["981\/13"],"award-info":[{"award-number":["981\/13"]}],"id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11046-018-0253-x","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T08:50:34Z","timestamp":1519894234000},"page":"659-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B"],"prefix":"10.1007","volume":"183","author":[{"given":"Daniel Brustolin","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Erzinger Alves","family":"de Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najeh Maissar","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Ereno","family":"Auler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4442-2075","authenticated-orcid":false,"given":"Rubiana Mara","family":"Mainardes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"253_CR1","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1016\/S0924-8579(08)70020-7","volume":"32","author":"BE Pauw de","year":"2008","unstructured":"de Pauw BE, Picazo JJ. Present situation in the treatment of invasive fungal infection. Int J Antimicrob Agents. 2008;32:S167\u201371.","journal-title":"Int J Antimicrob Agents"},{"key":"253_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2017.00036","volume":"8","author":"L Scorzoni","year":"2017","unstructured":"Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, et al. Antifungal therapy: new advances in the understanding and treatment of mycosis. Front Microbiol. 2017;8:1\u201323. \n                    https:\/\/doi.org\/10.3389\/fmicb.2017.00036\/full\n                    \n                  .","journal-title":"Front Microbiol"},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PGG Pappas","year":"2009","unstructured":"Pappas PGG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TFF, Edwards JE Jr, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society Of America. Clin Infect Dis. 2009;48:503\u201335. \n                    https:\/\/doi.org\/10.1086\/596757\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"253_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","volume":"17","author":"AL Colombo","year":"2013","unstructured":"Colombo AL, Guimar\u00e3es T, Camargo LFA, Richtmann R, de Queiroz-Telles F, Salles MJC, et al. Brazilian guidelines for the management of candidiasis\u2014a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;17:283\u2013312. \n                    https:\/\/doi.org\/10.1016\/j.bjid.2013.02.001\n                    \n                  .","journal-title":"Braz J Infect Dis"},{"key":"253_CR5","doi-asserted-by":"crossref","unstructured":"Figueras C, De Heredia CD, Garc\u00eda JJ, Navarro M, Ruiz-Contreras J, Rossich R, et al. Recomendaciones de la Sociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica sobre diagn\u00f3stico y tratamiento de la candidiasis invasiva. An. Pediatr\u00eda. 2011;74.","DOI":"10.1016\/j.anpedi.2010.12.012"},{"issue":"29","key":"253_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.eimc.2011.01.008","volume":"2011","author":"JM Aguado","year":"2011","unstructured":"Aguado JM, Ruiz-Camps I, Mu\u00f1oz P, Mensa J, Almirante B, V\u00e1zquez L, et al. Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC). Actualizaci\u00f3n 2011. Enferm Infecc Microbiol Clin. 2011;2011(29):345\u201361.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"253_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","volume":"3","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases\u2014estimate precision. J Fungi. 2017;3:57.","journal-title":"J Fungi"},{"key":"253_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jgar.2015.09.002","volume":"3","author":"A Busca","year":"2015","unstructured":"Busca A, Tortorano AM, Pagano L. Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients. J Glob Antimicrob Resist. 2015;3:237\u201341.","journal-title":"J Glob Antimicrob Resist"},{"key":"253_CR9","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1021\/ja00747a037","volume":"93","author":"P Ganis","year":"1971","unstructured":"Ganis P, Avitabile G, Mechlinski W, Schaffner CP. Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J Am Chem Soc. 1971;93:4560\u20134.","journal-title":"J Am Chem Soc"},{"key":"253_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1074-5521(01)00046-1","volume":"8","author":"P Caffrey","year":"2001","unstructured":"Caffrey P, Lynch S, Flood E, Finnan S, Oliynyk M. Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes. Chem Biol. 2001;8:713\u201323.","journal-title":"Chem Biol"},{"key":"253_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijpharm.2010.07.003","volume":"397","author":"S Sheikh","year":"2010","unstructured":"Sheikh S, Ali SM, Ahmad MU, Ahmad A, Mushtaq M, Paithankar M, et al. Nanosomal Amphotericin B is an efficacious alternative to Ambisome for fungal therapy. Int J Pharm. 2010;397:103\u20138. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2010.07.003\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"253_CR12","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1002\/jps.21179","volume":"97","author":"JJ Torrado","year":"2008","unstructured":"Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. Amphotericin B formulations and drug targeting. J Pharm Sci. 2008;97:2405\u201325.","journal-title":"J Pharm Sci"},{"key":"253_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0005-2736(01)00416-3","volume":"1558","author":"J Milhaud","year":"2002","unstructured":"Milhaud J, Ponsinet V, Takashi M, Michels B. Interactions of the drug amphotericin B with phospholipid membranes containing or not ergosterol: new insight into the role of ergosterol. Biochim Biophys Acta Biomembr. 2002;1558:95\u2013108.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"253_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","volume":"73","author":"RJ Hamill","year":"2013","unstructured":"Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73:919\u201334.","journal-title":"Drugs"},{"key":"253_CR15","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mycmed.2006.05.001","volume":"16","author":"B Deroure","year":"2006","unstructured":"Deroure B, Charpentier B, Saliba F, D\u00fcrrbach A. N\u00e9phrotoxicit\u00e9 de l\u2019amphot\u00e9ricine B: mise au point. J Mycol Med. 2006;16:82\u20136.","journal-title":"J Mycol Med"},{"key":"253_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","volume":"12","author":"P Boisseau","year":"2011","unstructured":"Boisseau P, Loubaton B. Nanomedicine, nanotechnology in medicine. Comptes Rendus Phys. 2011;12:620\u201336. \n                    https:\/\/doi.org\/10.1016\/j.crhy.2011.06.001\n                    \n                  .","journal-title":"Comptes Rendus Phys"},{"key":"253_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jconrel.2009.11.019","volume":"141","author":"DJA Crommelin","year":"2010","unstructured":"Crommelin DJA, Park K, Florence A. Pharmaceutical nanotechnology: unmet needs in drug delivery. J Control Release. 2010;141:263\u20134. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2009.11.019\n                    \n                  .","journal-title":"J Control Release"},{"key":"253_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.addr.2012.11.005","volume":"65","author":"L Mei","year":"2013","unstructured":"Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65:880\u201390. \n                    https:\/\/doi.org\/10.1016\/j.addr.2012.11.005\n                    \n                  .","journal-title":"Adv Drug Deliv Rev"},{"key":"253_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijpharm.2017.03.019","volume":"523","author":"GM Soliman","year":"2017","unstructured":"Soliman GM. Nanoparticles as safe and effective delivery systems of antifungal agents: achievements and challenges. Int J Pharm. 2017;523:15\u201332.","journal-title":"Int J Pharm"},{"key":"253_CR20","unstructured":"Kurtzman CP, Fell JW, Boekhout T. The yeasts: a taxonomic study, 5th ed. The Yeasts. 2011. \n                    http:\/\/www.scopus.com\/inward\/record.url?eid=2-s2.0-84895405314&partnerID=40&md5=a49dad735ebb1164df386c2cd38ee589\n                    \n                  ."},{"key":"253_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00713938","volume":"61","author":"E Gu\u00e9ho","year":"1992","unstructured":"Gu\u00e9ho E, Smith MT, de Hoog GS, Billon-Grand G, Christen R, Batenburg-van der Vegte WH. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek. 1992;61:289\u2013316.","journal-title":"Antonie Van Leeuwenhoek"},{"key":"253_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/10837450.2014.979942","volume":"21","author":"TCMM Carraro","year":"2016","unstructured":"Carraro TCMM, Khalil NM, Mainardes RM. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design. Pharm Dev Technol. 2016;21:140\u201346.","journal-title":"Pharm Dev Technol"},{"key":"253_CR23","first-page":"1","volume":"18","author":"M Arendrup","year":"2012","unstructured":"Arendrup M, Hope W, Lass-Fl\u00f6rl C, Cuenca-Estrella M, Arikan-Akdagli S, Barchiesi F, et al. Method for the determination of broth dilution minimum Inhibitory concentrations of antifungal agents for yeasts. Clin Microbiol Infect. 2012;18:1\u201321.","journal-title":"Clin Microbiol Infect"},{"key":"253_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.eimc.2012.02.003","volume":"30","author":"C Cervera","year":"2012","unstructured":"Cervera C. Candidemia y candidiasis invasora en el adulto. Formas cl\u00ednicas y tratamiento. Enferm Infecc Microbiol Clin. 2012;30:483\u201391.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"253_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","volume":"39","author":"NV Sipsas","year":"2012","unstructured":"Sipsas NV, Kontoyiannis DP. Invasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents. 2012;39:464\u201371. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.11.017\n                    \n                  .","journal-title":"Int J Antimicrob Agents"},{"key":"253_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.mycmed.2011.07.006","volume":"21","author":"Z Boucherit-Atmani","year":"2011","unstructured":"Boucherit-Atmani Z, Seddiki SML, Boucherit K, Sari-Belkharoubi L, Kunkel D. Candida albicans biofilms formed into catheters and probes and their resistance to amphotericin B. J Mycol Med. 2011;21:182\u20137.","journal-title":"J Mycol Med"},{"key":"253_CR27","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.2147\/IJN.S93105","volume":"11","author":"AR Voltan","year":"2016","unstructured":"Voltan AR, Quind\u00f3s G, Alarc\u00f3n KPM, Fusco-Almeida AM, Mendes-Giannini MJS, Chorilli M. Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? Int J Nanomed. 2016;11:3715\u201330.","journal-title":"Int J Nanomed"},{"key":"253_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","volume":"161","author":"H Ven Van de","year":"2012","unstructured":"Van de Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P, Kayaert P, et al. PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and Am Bisome. J Control Release. 2012;161:795\u2013803. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.037\n                    \n                  .","journal-title":"J Control Release"},{"key":"253_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jsps.2014.11.004","volume":"23","author":"BT AL-Quadeib","year":"2014","unstructured":"AL-Quadeib BT, Radwan MA, Siller L, Horrocks B, Wright MC. Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharm J. 2014;23:290\u2013302. \n                    https:\/\/doi.org\/10.1016\/j.jsps.2014.11.004\n                    \n                  .","journal-title":"Saudi Pharm J"},{"key":"253_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejps.2013.12.005","volume":"53","author":"Y Zu","year":"2014","unstructured":"Zu Y, Sun W, Zhao X, Wang W, Li Y, Ge Y, et al. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Eur J Pharm Sci. 2014;53:109\u201317.","journal-title":"Eur J Pharm Sci"},{"key":"253_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1166\/jnn.2015.9177","volume":"15","author":"DM Casa","year":"2015","unstructured":"Casa DM, Carraro TCMM, de Camargo LEA, Dalmolin LF, Khalil NM, Mainardes RM. Poly(L-lactide) nanoparticles reduce amphotericin B cytotoxicity and maintain its in vitro antifungal activity. J Nanosci Nanotechnol. 2015;15:848\u201354.","journal-title":"J Nanosci Nanotechnol"},{"key":"253_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejmech.2015.03.022","volume":"95","author":"ACO Souza","year":"2015","unstructured":"Souza ACO, Nascimento AL, de Vasconcelos NM, Jer\u00f4nimo MS, Siqueira IM, R-Santos L, et al. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles. Eur J Med Chem. 2015;95:267\u201376.","journal-title":"Eur J Med Chem"},{"key":"253_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4155\/tde.14.79","volume":"5","author":"SM Navarro","year":"2014","unstructured":"Navarro SM, Darensbourg C, Cross L, Stout R, Coulon D, Astete CE, et al. Biodistribution of PLGA and PLGA\/chitosan nanoparticles after repeat-dose oral delivery in F344 rats for 7 days. Ther Deliv. 2014;5:1191\u2013201.","journal-title":"Ther Deliv"},{"key":"253_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.trac.2015.06.014","volume":"80","author":"S Sharma","year":"2016","unstructured":"Sharma S, Parmar A, Kori S, Sandhir R. PLGA-based nanoparticles: A new paradigm in biomedical applications. TrAC Trends Anal Chem. 2016;80:30\u201340.","journal-title":"TrAC Trends Anal Chem"},{"key":"253_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jcis.2014.12.083","volume":"445","author":"S Alqahtani","year":"2015","unstructured":"Alqahtani S, Simon L, Astete CE, Alayoubi A, Sylvester PW, Nazzal S, et al. Cellular uptake, antioxidant and antiproliferative activity of entrapped \u03b1-tocopherol and \u03b3-tocotrienol in poly (lactic-co-glycolic) acid (PLGA) and chitosan covered PLGA nanoparticles (PLGA-Chi). J Colloid Interface Sci. 2015;445:243\u201351. \n                    https:\/\/doi.org\/10.1016\/j.jcis.2014.12.083\n                    \n                  .","journal-title":"J Colloid Interface Sci"},{"key":"253_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","volume":"238","author":"A Banerjee","year":"2016","unstructured":"Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176\u201385.","journal-title":"J Control Release"},{"key":"253_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","volume":"232","author":"M Lopes","year":"2016","unstructured":"Lopes M, Shrestha N, Correia A, Shahbazi MA, Sarmento B, Hirvonen J, et al. Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin. J Control Release. 2016;232:29\u201341. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2016.04.012\n                    \n                  .","journal-title":"J Control Release"},{"key":"253_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014a review. Int J Pharm. 2011;415:34\u201352. \n                    https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.049\n                    \n                  .","journal-title":"Int J Pharm"},{"key":"253_CR39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jiac.2014.05.009","volume":"20","author":"D Morii","year":"2014","unstructured":"Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, et al. Distribution of Candida species isolated from blood cultures in hospitals in Osaka, Japan. J Infect Chemother. 2014;20:558\u201362.","journal-title":"J Infect Chemother"},{"key":"253_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jiph.2013.08.002","volume":"7","author":"AF Alothman","year":"2014","unstructured":"Alothman AF, Al-Musawi T, Al-Abdely HM, Al Salman J, Almaslamani M, Yared N, et al. Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations. J Infect Public Health. 2014;7:6\u201319. \n                    https:\/\/doi.org\/10.1016\/j.jiph.2013.08.002\n                    \n                  .","journal-title":"J Infect Public Health"},{"key":"253_CR41","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125:S3\u201313. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2011.11.001\n                    \n                  .","journal-title":"Am J Med"},{"key":"253_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","volume":"11","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, D\u00edaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11:142\u201351. \n                    https:\/\/doi.org\/10.1016\/S1473-3099(10)70218-8\n                    \n                  .","journal-title":"Lancet Infect Dis"},{"key":"253_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s11046-013-9622-7","volume":"175","author":"FC Flores","year":"2013","unstructured":"Flores FC, de Lima JA, Ribeiro RF, Alves SH, Rolim CM, Beck RCR, et al. Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of Trichophyton rubrum. Mycopathologia. 2013;175:281\u20136.","journal-title":"Mycopathologia"},{"key":"253_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nano.2006.12.001","volume":"3","author":"JS Kim","year":"2007","unstructured":"Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med. 2007;3:95\u2013101.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"253_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jmii.2014.04.013","volume":"49","author":"ZK Xia","year":"2016","unstructured":"Xia ZK, Ma QH, Li SY, Zhang DQ, Cong L, Tian YL, et al. The antifungal effect of silver nanoparticles on Trichosporon asahii. J Microbiol Immunol Infect. 2016;49:182\u20138.","journal-title":"J Microbiol Immunol Infect"},{"key":"253_CR46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ijpharm.2013.02.038","volume":"447","author":"DR Serrano","year":"2013","unstructured":"Serrano DR, Hern\u00e1ndez L, Fleire L, Gonz\u00e1lez-Alvarez I, Montoya A, Ballesteros MP, et al. Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations. Int J Pharm. 2013;447:38\u201346.","journal-title":"Int J Pharm"},{"key":"253_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nano.2008.03.007","volume":"4","author":"M Nahar","year":"2008","unstructured":"Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotechnol Biol Med. 2008;4:252\u201361.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"253_CR48","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1166\/jnn.2015.11694","volume":"15","author":"DM Casa","year":"2015","unstructured":"Casa DM, Karam TK, Alves Ade C, Zgoda AA, Khalil NM, Mainardes RM. Bovine serum albumin nanoparticles containing amphotericin b: characterization, cytotoxicity and in vitro antifungal evaluation. J Nanosci Nanotechnol. 2015;15:10183\u20138.","journal-title":"J Nanosci Nanotechnol"},{"key":"253_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.mycmed.2017.07.004","volume":"27","author":"TCMM Carraro","year":"2017","unstructured":"Carraro TCMM, Altmeyer C, Khalil NM, Mainardes RM. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles. J Med Mycol. 2017;27:519\u201329.","journal-title":"J Med Mycol"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-018-0253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T21:09:03Z","timestamp":1551388143000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-018-0253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1007\/s11046-018-0253-x","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"17 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}